RENAL CELL CARCINOMA (RCC)
Clinical trials for RENAL CELL CARCINOMA (RCC) explained in plain language.
Never miss a new study
Get alerted when new RENAL CELL CARCINOMA (RCC) trials appear
Sign up with your email to follow new studies for RENAL CELL CARCINOMA (RCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo treatment for kidney cancer shows promise in early trial
Disease control CompletedThis study tested a two-step treatment for medium-sized kidney tumors (4.1-7 cm). First, doctors blocked the tumor's blood supply, then froze it. The goal was to see if this approach is safe and works well. 25 adults with stage T1b kidney cancer took part. The main focus was on s…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 26, 2026 06:01 UTC
-
New combo shows promise in kidney cancer fight
Disease control CompletedThis study tested whether adding epacadostat to the immunotherapy drug pembrolizumab works better than standard treatments (sunitinib or pazopanib) for people with advanced kidney cancer that has spread. The trial included 129 patients who had not received prior therapy. Research…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
AI reads CT scans to spot rare kidney cancer before surgery
Knowledge-focused CompletedThis study looked at CT scans from 746 kidney cancer patients to see if a computer model could predict a rare type called MIT family translocation kidney cancer. The goal was to help doctors diagnose this cancer before surgery, leading to more personalized treatment. The research…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Sponsor: First Affiliated Hospital of Fujian Medical University • Aim: Knowledge-focused
Last updated May 26, 2026 06:06 UTC
-
AI and PET/MRI join forces to decode tumor aggressiveness
Knowledge-focused CompletedThis study tested whether combining PET/MRI scans with machine learning can more accurately determine how aggressive solid tumors like prostate cancer are. Researchers scanned 50 adults with prostate, liver, kidney, or brain tumors and compared the AI results to standard tissue a…
Matched conditions: RENAL CELL CARCINOMA (RCC)
Sponsor: Ciprian Catana, MD, PhD • Aim: Knowledge-focused
Last updated May 26, 2026 05:59 UTC